Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Adlai Nortye Announces Clinical Collaboration with Merck to Evaluate Adlai Nortye's AN0025 (EP4 Antagonist) in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors 2019-01-03 16:00
Gathering Hotspots of the Preparation Industry, In Step with the International Pharmaceutical Trends 2019-01-03 15:00
Sinovant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference 2019-01-03 09:00
Ascletis' IND Filing for Its Third HCV Drug ASC21 Accepted by NMPA 2019-01-03 08:00
Connect Biopharmaceuticals Completes $55 Million Series B Financing to Accelerate Clinical Development of Novel Immune Modulators 2019-01-03 03:15
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering 2019-01-03 02:30
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering 2019-01-03 02:30
MabSpace Biosciences Merged with HJB to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company 2019-01-02 12:37
Antengene Corporation Raises $120 Million in Series B Financing 2019-01-02 08:45
Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Esophageal Cancer 2019-01-02 08:00
Luye Pharma Announces Innovative Drug - Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process 2018-12-31 08:00
InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer 2018-12-29 03:33
Bridge Biotherapeutics Announces a Successful Activation of U.S. Clinical Trial Sites for BBT-401 Phase 2 Study 2018-12-28 07:00
China's NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin's Lymphoma 2018-12-27 16:45
Focusing on CRO & CMO Industry Upgrading, ICSE China 2019 Helps Enterprises Seize New Industry Opportunities 2018-12-25 15:00
I-Mab Receives U.S. FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2 2018-12-24 11:45
Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat 2018-12-21 21:46
CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way 2018-12-21 17:50
Mundipharma Applies to Market Remimazolam for General Anesthesia in Japan 2018-12-21 15:14
Gan & Lee and a Leading Pharmaceutical Company Enters into Global Collaboration to Commercialize Insulin Analog 2018-12-19 19:22
1 337 338 339 340 341 410